16-89733333-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001113525.2(ZNF276):c.1201G>A(p.Ala401Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000273 in 1,614,166 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001113525.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152260Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000637 AC: 16AN: 251286Hom.: 0 AF XY: 0.0000736 AC XY: 10AN XY: 135862
GnomAD4 exome AF: 0.0000253 AC: 37AN: 1461788Hom.: 0 Cov.: 31 AF XY: 0.0000344 AC XY: 25AN XY: 727182
GnomAD4 genome AF: 0.0000459 AC: 7AN: 152378Hom.: 0 Cov.: 33 AF XY: 0.0000805 AC XY: 6AN XY: 74514
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 02, 2024 | The c.1201G>A (p.A401T) alteration is located in exon 7 (coding exon 7) of the ZNF276 gene. This alteration results from a G to A substitution at nucleotide position 1201, causing the alanine (A) at amino acid position 401 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at